Literature DB >> 3501079

MPTP metabolites inhibit rat brain glutathione S-transferases.

Y C Awasthi1, S V Singh, R S Shen, C W Abell, W Gessner, A Brossi.   

Abstract

1-Methyl-4-phenyl-2,3-dihydropyridinium and 1-methyl-4-phenyl-pyridinium species, metabolites of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, non-competitively inhibit glutathione S-transferases of rat brain in vitro. The Ki values for 1-methyl-4-phenyl-2,3-dihydropyridinium bromide and 1-methyl-4-phenyl-pyridinium bromide are 0.67 and 0.3 mM, respectively. Inhibition of these enzymes may lead to impairment of cellular defense mechanisms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3501079     DOI: 10.1016/0304-3940(87)90358-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  GSTpi expression mediates dopaminergic neuron sensitivity in experimental parkinsonism.

Authors:  Michelle Smeyne; Justin Boyd; Kennie Raviie Shepherd; Yun Jiao; Brooks Barnes Pond; Matthew Hatler; Roland Wolf; Colin Henderson; Richard Jay Smeyne
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

2.  Dopaminergic system activity and cellular defense mechanisms in the striatum and striatal synaptosomes of the rat subchronically exposed to manganese.

Authors:  M S Desole; M Miele; G Esposito; R Migheli; L Fresu; G De Natale; E Miele
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

Review 3.  Glutathione metabolism and Parkinson's disease.

Authors:  Michelle Smeyne; Richard Jay Smeyne
Journal:  Free Radic Biol Med       Date:  2013-05-08       Impact factor: 7.376

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.